ARTICLES

Great Lakes 推出獨特的客製化 MARPE 裝置——針對上顎橫向缺損的現代化解決方案
牙科睡眠醫學

Great Lakes 推出獨特的客製化 MARPE 設備

Great Lakes 客製化 MARPE(微型螺釘輔助快速腭擴張器)可根據患者的獨特需求進行客製化調整。為達到預期的擴張效果,所需微型螺釘的數量與位置均由醫師指定。個性化的裝置設計與策略性的微型植體植入位置,有助於實現有效的治療。Great Lakes 技術嫻熟的技術人員將提供 […]

HoneyNaps 的人工智慧睡眠分析裝置獲得美國食品藥物管理局(FDA)核准
人工智慧在睡眠醫學中的應用

HoneyNaps 的人工智慧睡眠分析裝置獲得美國食品藥物管理局(FDA)核准

以人工智慧為基礎的睡眠醫學公司 HoneyNaps 宣布,其用於多導睡眠圖(PSG)分析的人工智慧診斷軟體 SOMNUM V3.0,已獲得美國食品藥物管理局(FDA)核准,核准編號為 K253390。SOMNUM 是一款臨床決策支援軟體,旨在協助醫療專業人員分析多導睡眠圖數據,包括睡眠分期與 […]

睡眠不足會導致體重增加
臨床研究與發現

睡眠不足會導致體重增加

People who shortened their sleep by around 80 minutes a night for six weeks gained weight—one pound on average—and were more sedentary, researchers at Columbia University Vagelos College of Physicians and Surgeons have found. “Our study shows that getting adequate sleep may help reduce the risk of weight gain and obesity-related […]

TAP Sleep Care 發表 myTAP 案例研究,顯示阻塞性睡眠呼吸中止症(OSA)症狀迅速改善
牙科睡眠醫學

TAP Sleep Care 發表 myTAP 案例研究,顯示阻塞性睡眠呼吸中止症(OSA)症狀迅速改善

TAP Sleep Care® announced the publication of a compelling case report demonstrating the rapid, near-complete effectiveness of its myTAP® chairside titratable oral appliance when combined with a mouth shield for nasal breathing. Case #13 titled, “Two-Night Breakthrough in Treatment-Resistant OSA: Immediate-Effective Outcomes by combining Chairside OA with Mouth Shield,” authored […]

apnimed 首次公開募股 納斯達克
Industry News & Updates Sleep Pharmaceuticals

Apnimed 提交首次公開募股申請,其每日僅需服用一次的 OSA 藥丸即將獲得美國食品藥物管理局(FDA)的審核決定

Apnimed, the company behind what could become the first oral pharmacotherapy for obstructive sleep apnea (OSA), has filed for an initial public offering in the United States. The company is expected to list on Nasdaq under the ticker APMD. The filing comes at a notable moment for the biotech sector. [...]
Addex Announces Publication of Research Highlighting Therapeutic Potential of mGlu7 Modulation in Regulating Sleep and Wakefulness
臨床研究與發現

Addex Research 強調調節 mGlu7 在控制睡眠與清醒方面的治療潛力

Addex Therapeutics announced publication of new preclinical research demonstrating that ADX71743, a selective negative allosteric modulator (NAM) of metabotropic glutamate receptor 7 (mGlu7), significantly modulates sleep-wake regulation and stress-related neurochemistry in animal models. The data, published in the International Journal of Neuropsychopharmacology, expands the growing body of evidence supporting mGlu7 […]

sovaSage Introduces AI-Powered Clinical Indicator Intelligence™
人工智慧在睡眠醫學中的應用

sovaSage 推出由人工智慧驅動的臨床指標分析解決方案,以提升肺動脈壓(PAP)患者的管理成效

sovaSage™ announced the new release of Clinical Indicator Intelligence™, an enhanced feature within sovaGuide™ featuring Jeanie™. Using machine learning, the new capability continuously analyzes multiple PAP therapy variables to help providers identify patients who may require additional clinical evaluation before therapy challenges lead to reduced benefit or treatment abandonment. The […]